CT4ARDS-2: Quantitative Computed Tomography for Mortality Risk Stratification in ARDS

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Recruiting
CT.gov ID
NCT06113276
Collaborator
(none)
210
4
53.8
52.5
1

Study Details

Study Description

Brief Summary

Acute respiratory distress syndrome remains a deadly disease with hospital mortality remaining between 40 to 50%. ARDS mortality risk factors have been identified from patient history, common clinical and biological variables in the lung SAFE study. Part of ARDS mortality is attributable to ventilator-induced lung injury (VILI), in relation with inappropriate settings on the ventilator. Tidal hyperinflation and recruitment/derecruitment during lung inflation are 2 identified mechanisms leading to VILI, that may be identified on computed tomography while poorly identified with variables collected at the bedside.

The aim of this study is to identify whether tidal hyperinflation identified on computed tomography is a risk factor for ARDS mortality, independently from know bio-clinical risk factors.

Condition or Disease Intervention/Treatment Phase
  • Radiation: Low dose computed tomography to evaluate biomechanical parameters in the lung

Study Design

Study Type:
Observational
Anticipated Enrollment :
210 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Quantitative Computed Tomography for Mortality Risk Stratification in ARDS
Actual Study Start Date :
Nov 6, 2020
Anticipated Primary Completion Date :
Nov 1, 2024
Anticipated Study Completion Date :
May 1, 2025

Arms and Interventions

Arm Intervention/Treatment
tidal hyperinflation

As the study aim to identify whether tidal hyperinflation is an independent predictor for ARDS mortality, and as this variable will be entered as a quantitative predictor in the multivariate model, the study encompass a single group of patient (i.e. all included patients)

Radiation: Low dose computed tomography to evaluate biomechanical parameters in the lung
In the participating to the study, response to PEEP increase and tidal inflation are evaluated with a software computing biomechanical parameters (tidal hyperinflation and lung recruitability). Tidal hyperinflation and recruitment are computed on CT images acquired within 72 hours after ARDS onset or with 72h after ECMO onset.

Outcome Measures

Primary Outcome Measures

  1. Odd ratio of tidal hyperinflation assessed on CT at day-0 as an independent predictor of 90-day mortality [Day-0 (time of realization of CT scan)]

    Tidal hyperinflation is computed as the volume difference of hyperinflated lung (i.e., with CT attenuation between -1000 and -900 Hounsfield units) between and-expiration and end-inspiration at the PEEP level chosen by clinician

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
    1. Patient aged 15 or older with ARDS according to the Berlin definition 2. invasive mechanical ventilation with PaO2/FiO2 ≤ 300 mm Hg 3. with computed tomography acquired at both end-expiration and end-inspiration, or at both PEEP 5 and 15 cm H2O at end-expiration 4. PEEP setting according to a PEEP/FiO2 table, with secondary adjustment according to hemodynamic tolerance 5. Tidal volume 6 ml/kg of predicted body weight or less
Exclusion Criteria:
    1. Use of contrast agent during computed tomography acquisition 2. ARDS criteria onset since more than 72 hours or ECMO onset since more than 72 hours 3. Proven COPD 4. Pneumothorax or bronchopleural fistula 5. Patient with spontaneous breathing preventing realization of end-expiratory and end-inspiratory pauses 6. Previous inclusion in current study 7. Patient under a legal protective measure

Contacts and Locations

Locations

Site City State Country Postal Code
1 Service de Médecine Intensive Réanimation Hôpital Michallon - CHU Grenoble Alpes La Tronche France 38700
2 Hospices Civils de Lyon - Hôpital de la Croix Rousse - Service de Médecine Intensive Réanimation Lyon France 69004
3 Service de Réanimation Polyvalente Centre Hospitalier Lyon Sud Hospices Civils de Lyon Pierre-Bénite France 69310
4 Centre Hospitalier Universitaire de Rennes Rennes France

Sponsors and Collaborators

  • Hospices Civils de Lyon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT06113276
Other Study ID Numbers:
  • 69HCL21_0664
  • 194_v3
First Posted:
Nov 2, 2023
Last Update Posted:
Nov 2, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospices Civils de Lyon
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 2, 2023